June 16 (Reuters) - Eli Lilly and Co LLY.N:
LILLY TO OFFER ALL APPROVED DOSES OF ZEPBOUND (TIRZEPATIDE) SINGLE-DOSE VIALS THROUGH LILLYDIRECT SELF PAY PHARMACY SOLUTIONS
ELI LILLY AND CO - ALL APPROVED ZEPBOUND DOSES AVAILABLE FOR $499/MONTH OR LESS
ELI LILLY AND CO - 12.5 MG AND 15 MG ZEPBOUND VIALS AVAILABLE FOR PRESCRIPTION JULY 7
Source text: ID:nPn24xrdSa
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。